Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118288) titled 'A single-arm phase II clinical study of chemotherapy combined with immunotherapy followed by radiotherapy for residual lesions in oligometastatic esophageal squamous cell carcinoma' on Feb. 4.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Anhui Provincial Cancer Hospital

Condition: Esophageal squamous cell carcinoma

Recruitment Status: Recruiting

Phase: 0

Date of First Enrollment: 2026-02-06

Target Sample Size: Chemotherapy-immunotherapy sequential radiotherapy:30;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=307452

D...